The 2nd ENABLE symposium entitled “The promise of future medicine: from research to therapy” will be hosted in Copenhagen, from 7 - 9 November.ENABLE is unique because world-class scientific content is combined with focus on development of “soft skills” in workshops and career chats. There will also be a job with various types of companies and foundations, ranging from publishers to consultancy. Rimls supports the attendance of our young researchers to this symposium.
Don’t miss out, registration closes 30 September. For registration and more information on this year’s event, check out: link.
Want to know more about these subjects? Click on the buttons below for more news.
RIMLSNanomedicine Cancer development and immune defenseRare cancersTumors of the digestive tract Urological cancersWomen's cancersInfectious diseases and global healthInflammatory diseases Metabolic disordersReconstructive and regenerative medicineRenal disorders Vascular damage Disorders of movement
Related news items
Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview22 July 2021
Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.read more
Michiel Vermeulen and Klaas Mulder receive funding from ZonMw for a collaborative project using stem cell-based models15 July 2021
Michiel Vermeulen and Klaas Mulder, theme Cancer development and immune defense, receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis.read more
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development15 July 2021
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortiumread more